Literature DB >> 25491618

Acute high dose-fentanyl exposure produces hyperalgesia and tactile allodynia after coronary artery bypass surgery.

V Yildirim1, S Doganci, S Cinar, M B Eskin, G Ozkan, S Eksert, M E Ince, A Dogrul.   

Abstract

OBJECTIVE: Opioid-induced hyperalgesia is well known complication of acute high dose and chronic opioid therapy. In this study, we evaluated development of opioid-induced hyperalgesia following intraoperative short-term use of µ-opioid agonist fentanyl after coronary artery bypass surgery. PATIENTS AND METHODS: 100 patients undergoing elective coronary artery bypass graft surgery is divided into two groups. In group I (low dose), anesthesia was induced with propofol 1-2.5 mg/kg and fentanyl 2 mcg/kg, in group II (high dose) fentanyl 40-70 mcg/kg was used. In group I, propofol 5-10 mg/kg/h, fentanyl 1-3 mcg/kg/h, in group II fentanyl 5-10 mcg/kg/h was used for maintenance of anesthesia. The tactile and thermal thresholds were measured before surgery and in 1st, 3rd and 7th postoperative days by using Von Frey filaments and a thermal source, respectively.
RESULTS: Tactile thresholds were significantly decreased at the first (6,08±0.21 and 3.76±0.13 g; p<0.001) and third (6.76±0.24 and 4.96±0.16 g; p<0.001) postoperative days compared to baseline preoperative values (7.72±0.26, and 7.60±0.21 g; p=816) in two groups. Postoperative 1st (13.45±0.33 and 10.05±0.24 sec; p<0.001) and 3rd day (14.77±0.28 and 13.17±0.26 sec; p<0.001) assessments showed a statistically significant thermal hyperalgesia compared to the preoperative baseline values (16.67±0.51 and 16.45±0.42 sec; p=0.997) in two groups. This decrease in both tactile and thermal thresholds returned to baseline control values at the 7th day of measurement.
CONCLUSIONS: Our results showed that patients undergoing coronary artery bypass surgery receiving fentanyl anesthesia developed postoperative tactile allodynia and thermal hyperalgesia and this was more prominent in high dose group.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25491618

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  6 in total

1.  In Vitro Nociceptor Neuroplasticity Associated with In Vivo Opioid-Induced Hyperalgesia.

Authors:  Eugen V Khomula; Dioneia Araldi; Jon D Levine
Journal:  J Neurosci       Date:  2019-07-12       Impact factor: 6.167

2.  Opioid-Induced Hyperalgesic Priming in Single Nociceptors.

Authors:  Eugen V Khomula; Dionéia Araldi; Ivan J M Bonet; Jon D Levine
Journal:  J Neurosci       Date:  2020-11-17       Impact factor: 6.167

Review 3.  When pain gets stuck: the evolution of pain chronification and treatment resistance.

Authors:  David Borsook; Andrew M Youssef; Laura Simons; Igor Elman; Christopher Eccleston
Journal:  Pain       Date:  2018-12       Impact factor: 7.926

Review 4.  New Insights Into the Pharmacological Management of Postoperative Pain: A Narrative Review.

Authors:  Victor Mayoral Rojals; Moises Charaja; Oscar De Leon Casasola; Antonio Montero; Marco Antonio Narvaez Tamayo; Giustino Varrassi
Journal:  Cureus       Date:  2022-03-10

5.  Effects of Intraoperative Opioid Administration on Postoperative Pain and Pain Threshold: A Randomized Controlled Study.

Authors:  Ryoko Kawanaka; Shoko Sakuma; Hiroshi Kokubun; Shuhei Tetsu; Yugo Tagaito; Toshio Igarashi; Shan-Guang Liang; Tomohiko Aoe
Journal:  J Clin Med       Date:  2022-09-23       Impact factor: 4.964

6.  A Sufentanil-Based Rapid Cardiac Anesthesia Regimen in Children Undergoing Percutaneous Minimally-Invasive Intraoperative Device Closure of Ventricular Septal Defect.

Authors:  Zeng-Chun Wang; Qiang Chen; Ling-Shan Yu; Liang-Wan Chen; Gui-Can Zhang
Journal:  Braz J Cardiovasc Surg       Date:  2020-06-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.